Early Feasibility Study of Medtronic OmniaSecure Model 3930M Defibrillation Lead Implantation Via the Middle Cardiac Vein in Patients With Tricuspid Valve Regurgitation: MCV3930 EFS

Inclusion Criteria: 1. Subject meets current clinical practice guidelines for implantation of ICD or CRT-D and will undergo one of the following: * Medtronic CRT-D system implant * Medtronic ICD system implant (single or dual chamber) 2. Anatomical suitability for middle cardiac vein lead placement based on pre procedural imaging. 3. Subject meets both of the following: * At least Moderate Tricuspid Valve Regurgitation documented by cardiac imaging * A clinical goal to avoid worsening tricuspid valve regurgitation as determined by the treating physician and/or the patient 4. Age…